126 related articles for article (PubMed ID: 10992434)
1. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation.
Boden SD
Tissue Eng; 2000 Aug; 6(4):383-99. PubMed ID: 10992434
[TBL] [Abstract][Full Text] [Related]
2. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1).
Boden SD; Titus L; Hair G; Liu Y; Viggeswarapu M; Nanes MS; Baranowski C
Spine (Phila Pa 1976); 1998 Dec; 23(23):2486-92. PubMed ID: 9854747
[TBL] [Abstract][Full Text] [Related]
3. Overcoming the immune response to permit ex vivo gene therapy for spine fusion with human type 5 adenoviral delivery of the LIM mineralization protein-1 cDNA.
Kim HS; Viggeswarapu M; Boden SD; Liu Y; Hair GA; Louis-Ugbo J; Murakami H; Minamide A; Suh DY; Titus L
Spine (Phila Pa 1976); 2003 Feb; 28(3):219-26. PubMed ID: 12567021
[TBL] [Abstract][Full Text] [Related]
4. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
5. Posterolateral lumbar spine fusion with INFUSE bone graft.
Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo.
Viggeswarapu M; Boden SD; Liu Y; Hair GA; Louis-Ugbo J; Murakami H; Kim HS; Mayr MT; Hutton WC; Titus L
J Bone Joint Surg Am; 2001 Mar; 83(3):364-76. PubMed ID: 11263640
[TBL] [Abstract][Full Text] [Related]
7. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute.
Boden SD
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S26-31. PubMed ID: 12205416
[TBL] [Abstract][Full Text] [Related]
8. Graft options in posterolateral and posterior interbody lumbar fusion.
Rihn JA; Kirkpatrick K; Albert TJ
Spine (Phila Pa 1976); 2010 Aug; 35(17):1629-39. PubMed ID: 20628336
[TBL] [Abstract][Full Text] [Related]
9. The Marshall R. Urist Young Investigator Award. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2.
Morone MA; Boden SD; Hair G; Martin GJ; Racine M; Titus L; Hutton WC
Clin Orthop Relat Res; 1998 Jun; (351):252-65. PubMed ID: 9646769
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins for spinal fusion.
Carlisle E; Fischgrund JS
Spine J; 2005; 5(6 Suppl):240S-249S. PubMed ID: 16291119
[TBL] [Abstract][Full Text] [Related]
11. What bone graft substitutes should we use in post-traumatic spinal fusion?
Guerado E; Fuerstenberg CH
Injury; 2011 Sep; 42 Suppl 2():S64-71. PubMed ID: 21839997
[TBL] [Abstract][Full Text] [Related]
12. Updates in the use of bone grafts in the lumbar spine.
Park JJ; Hershman SH; Kim YH
Bull Hosp Jt Dis (2013); 2013; 71(1):39-48. PubMed ID: 24032582
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of bone formation with gene transfer of the cDNA encoding for the intracellular protein LMP-1.
Minamide A; Boden SD; Viggeswarapu M; Hair GA; Oliver C; Titus L
J Bone Joint Surg Am; 2003 Jun; 85(6):1030-9. PubMed ID: 12783998
[TBL] [Abstract][Full Text] [Related]
14. Spine fusion by gene therapy.
Yoon ST; Boden SD
Gene Ther; 2004 Feb; 11(4):360-7. PubMed ID: 14724678
[TBL] [Abstract][Full Text] [Related]
15. Current use of biologic graft extenders for spinal fusion.
Coseo NM; Saldua N; Harrop J
J Neurosurg Sci; 2012 Sep; 56(3):203-7. PubMed ID: 22854588
[TBL] [Abstract][Full Text] [Related]
16. LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation.
Boden SD; Liu Y; Hair GA; Helms JA; Hu D; Racine M; Nanes MS; Titus L
Endocrinology; 1998 Dec; 139(12):5125-34. PubMed ID: 9832452
[TBL] [Abstract][Full Text] [Related]
17. Evidence supporting the use of bone morphogenetic proteins for spinal fusion surgery.
Robinson Y; Heyde CE; Tschöke SK; Mont MA; Seyler TM; Ulrich SD
Expert Rev Med Devices; 2008 Jan; 5(1):75-84. PubMed ID: 18095899
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for spine fusion.
Khan SN; Hidaka C; Sandhu HS; Girardi FP; Cammisa FP; Diwan AD
Orthop Clin North Am; 2000 Jul; 31(3):473-84. PubMed ID: 10882472
[TBL] [Abstract][Full Text] [Related]
19. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008.
Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK
Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827
[TBL] [Abstract][Full Text] [Related]
20. Carrier materials for spinal fusion.
Kwon B; Jenis LG
Spine J; 2005; 5(6 Suppl):224S-230S. PubMed ID: 16291117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
